Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects

Biological Psychiatry

Volumn 54, Issue 12, 2003, Pages 1382-1388

  Sautter, Frederic J ^a,b   Bissette, Garth ^c   Wiley, Justin ^a   Manguno Mire, Gina ^a   Schoenbachler, Benjamin ^a   Myers, Leann ^d   Johnson, Janet E ^a   Cerbone, Arleen ^b   Malaspina, Dolores ^e,f  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY   (United States)

^e Howard Hughes Medical Institute   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Comorbidity; Corticotropin releasing factor; HPA axis; Psychosis; PTSD; Somatostatin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; SOMATOSTATIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; HORMONE DETERMINATION; HUMAN; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSIS;

EID: 0346850971     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00571-7     Document Type: Article

References (45)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed :1994;American Psychiatric Association, Washington, DC.
2. Structured Clinical Interview for DSM-IV-PTSD Module. 1995;American Psychiatric Press, New York.
3. Baker D.G., West S.A., Nicholson W.E., Ekhator N.N., Kasckow J.W., Hill K.K. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress. Am J Psychiatry. 156:1999;585-588.
4. Banki C.M., Bissette G., Arato M., O'Conner L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry. 144:1987;873-877.
5. Bremner J.D., Licinio J., Darnell A., Krystall J.H., Owens M.J., Southwick S.M. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 154:1997;624-629.
6. Butler R.W., Mueser K.T., Sprock J., Braff D.L. Positive symptoms of psychosis in posttraumatic stress disorder. Biol Psychiatry. 39:1996;839-844.
7. Cerbone A, Sautter FJ, Evans WE, Manguno-Mire G, Wiley J, Tomlin H, et al (in press): Differences in smooth pursuit eye movement between posttraumatic stress disorder and schizophrenia. Schizophr Res.
8. Charney D.S., Deutch A.Y., Krystal J.H., Southwick S.M., Davies M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry. 50:1993;294-305.
9. David D., Kutcher G.S., Jackson E.I., Mellman T.A. Psychotic symptoms in PTSD. J Clin Psychiatry. 60:1997;29-32.
10. Davidson J.T., Hughes D., Blazer D., George L. Post-traumatic stress disorder in the community An epidemiological study . Psychol Med. 21:1991;1-9.
11. Deutch A.Y., Bean A.J., Bissette G., Nemeroff C.B., Robbins R.J., Roth R.H. Stress-induced alterations in neurotensin, somatostatin, and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res. 417:1987;350-354.
12. Fadda P., Pani L., Porcella A., Fratta W. Chronic imipramine, l-sulpiride and mianserin decrease corticotropin-releasing factor levels in the rat brain. Neurosci Lett. 192:1995;121-123.
13. Forman S.D., Bissette G., Yao J., Nemeroff C.B., van Kammen D.P. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenics. Schizophr Res. 12:1994;43-51.
14. Hamner M.B. Psychotic features and combat-associated PTSD. Depression Anxiety. 5:1997;34-38.
15. Hamner M.B., Frueh B.C., Ulmer H.G., Arana W.A. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 45:1999;846-852.
16. Hamner M.B., Frueh B.C., Ulmer H.G., Huber M.G., Twomey T.J., Tyson C., Arana G.W. Psychotic features in chronic posttraumatic stress disorder and schizophrenia Comparative severity . J Nerv Men Dis. 188:2000;217-221.
17. Hamner M.M., Fossey M.D. Psychotic symptoms associated with posttraumatic stress disorder. Neuropsychopharmacol. 9:(suppl):1993;S121-S122.
18. Hatzimanolis J., Lykouras L., Markianos M., Oulis P. Neurochemical variables in schizophrenic patients during switching from neuroleptics from clozapine. Prog Neuropsychopharmacol Biol Psychiatry. 22:1998;1077-1085.
19. Holsboer F. The corticosteroid hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
20. Iacono W.G., Moreau M., Beiser M., Fleming J.A.E., Lin T.Y. Smooth-pursuit eye tracking in first-episode psychotic patients and their relatives. J Abnorm Psychol. 101:1992;104-116.
21. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures Role of corticosterone . Eur J Pharmacol. 165:1989;337-338.
22. Makino S., Shibasaki T., Yamauchi N., Nishioka T., Mimoto T., Wakabayashi I., et al. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala, but not in the hypothalamic paraventricular nucleus in the rat. Brain Res. 850:1999;136-143.
23. Markianos M., Hatzimanolis J., Lykouras L. Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone. Psychopharmacology (Berl). 143:1999;270-272.
24. McFarlane A.C., Bookless C., Air T. Posttraumatic stress disorder in a general psychiatric inpatient population. J Trauma Stress. 14:2001;633-645.
25. Mueser K.T., Butler R.W. Auditory hallucinations in combat-related chronic posttraumatic stress disorder. Am J Psychiatry. 144:1987;299-302.
26. Mueser K.T., Goodman L.B., Trumbetta S.L., Rosenberg S.D., Osher C., Vidaver R., et al. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 66:1998;493-500.
27. Nemeroff C.B., Bissette G., Akil H., Fink M. Cerebrospinal fluid neuropeptides in depressed patients treated with ECT Corticotropin-releasing factor, beta-endorphin, and somatostatin . Br J Psychiatry. 158:1991;59.
28. Owens M.J., Nemeroff C.B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders Laboratory and clinical studies . Ciba Found Symposium. 172:1993;296-313.
29. Posener J.A., Schatzberg A.F., Williams G.H., Samson J.A., McHale N.L., Bessette M.P., et al. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biol Psychiatry. 45:1999;222-228.
30. Rothschild A.J., Langlais P.J., Schatzberg A.F., Miller M.M., Salomon M.S., Lerbinger J.E. The effects of a single dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 36:1985;2491-2501.
31. Rothschild A.J., Langlais P.J., Schatzberg A.F., Walsh F.X., Cole J.O., Bird E.D. Dexamethasone increases plasma free dopamine in man. J Psychiatr Res. 3:1984;217-223.
32. Rothschild A.J., Schatzberg A.F., Langlais P.J., Lerbinger J.E., Miller M.M., Cole J.O. Psychotic and nonpsychotic depressions I. Comparison of plasma catecholamines and cortisol measures . Psychiatry Res. 20:1987;143-153.
33. Salin P., Mercugliano M., Chesselet M.F. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens and frontal cortex of the rat. Cell Mol Neurobiol. 10:1990;127-144.
34. Sautter F.J., Brailey K., Uddo M.M., Hamilton M.F., Beard M.G., Borges A.H. PTSD and comorbid psychotic disorders Comparisons of veterans diagnosed with PTSD or with psychotic disorder . J Trauma Stress. 12:1999;73-88.
35. Sautter F.J., Johnson J., Cornwell J., Wiley J., Faraone S.V. Familial psychopathology in a PTSD subtype with secondary psychotic symptoms. Am J Psychiatry. 159:2002;1775-1777.
36. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., Cole E.J. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatry Res. 19:1985;57-64.
37. Scheepers F.E., Gespen de Weid C.C., Kahn R.S. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia. J Clin Psychopharmacol. 21:2001;575-582.
38. Sharma R.P., Bissette G., Janicak P., Davis J.M., Nemeroff C.B. Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder The effects of antipsychotic treatment . Schizophr Res. 13:1994;173-177.
39. Smith M.A., Davidson J., Richie J.C., Kudler H., Lipper C. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry. 26:1989;349-355.
40. Wilcox J.A., Briones D.F., Suess L. Auditory hallucinations, posttraumatic stress disorder, and ethnicity. Compr Psychiatry. 32:1991;320-323.
41. Wolkowitz O.M., Sutton M.E., Doran A.R., Labarca R., Roy A., Thomas J.W., et al. Dexamethasone increases plasma HVA but not MHPG in normal humans. Psychiatry Res. 16:1985;101-109.
42. Wolkowitz O.M., Sutton M.E., Koulu M., Labarca R., Wilkinson L., Doran A., et al. Chronic corticosterone administration in rats Behavioral and biochemical evidence of increased central dopaminergic activity . Eur J Pharmacol. 122:1986;329-338.
43. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 62:(suppl17):2001;41-46.
44. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry. 52:1995;583-592.
45. Yehuda R., Kahana B., Binder-Brynes K., Southwick S.M., Mason J.W., Giller E.L. Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder. Am J Psychiatry. 152:1995;982-986.